Original articles
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Rosa M.R. Pereiraa, Marilia A. Dagostina,
, Valeria F. Caparboa, Lucas P. Salesa, Sandra G. Pasotoa, Clovis A. Silvab, Emily F.N. Yukia, Carla G.S. Saada, Ana C. Medeiros-Ribeiroa, Leonard V.K. Kupaa, Solange R.G. Fuscoa, Victor A.O. Martinsa, Carolina C.M.F. Martinsa, Carmen Valente Barbasc, Samuel K. Shinjoa, Nadia E. Aikawaa,b, Eloisa Bonfaa
Corresponding author
a Rheumatology Division, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
b Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, Brazil
c Pulmonary Division, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
Read
2132
Timeswas read the article
512
Total PDF
1620
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 10 | 28 |
| 2025 11 | 94 | 55 | 149 |
| 2025 10 | 51 | 16 | 67 |
| 2025 9 | 34 | 38 | 72 |
| 2025 8 | 37 | 17 | 54 |
| 2025 7 | 66 | 7 | 73 |
| 2025 6 | 54 | 4 | 58 |
| 2025 5 | 37 | 3 | 40 |
| 2025 4 | 31 | 3 | 34 |
| 2025 3 | 36 | 3 | 39 |
| 2025 2 | 43 | 7 | 50 |
| 2025 1 | 35 | 3 | 38 |
| 2024 12 | 36 | 1 | 37 |
| 2024 11 | 56 | 17 | 73 |
| 2024 10 | 48 | 22 | 70 |
| 2024 9 | 69 | 22 | 91 |
| 2024 8 | 68 | 20 | 88 |
| 2024 7 | 66 | 27 | 93 |
| 2024 6 | 60 | 19 | 79 |
| 2024 5 | 78 | 27 | 105 |
| 2024 4 | 74 | 25 | 99 |
| 2024 3 | 78 | 19 | 97 |
| 2024 2 | 60 | 29 | 89 |
| 2024 1 | 57 | 20 | 77 |
| 2023 12 | 63 | 28 | 91 |
| 2023 11 | 34 | 18 | 52 |
| 2023 10 | 37 | 11 | 48 |
| 2023 9 | 31 | 15 | 46 |
| 2023 8 | 48 | 5 | 53 |
| 2023 7 | 17 | 7 | 24 |
| 2023 6 | 29 | 12 | 41 |
| 2023 5 | 35 | 2 | 37 |
| 2023 4 | 18 | 0 | 18 |
| 2023 3 | 5 | 0 | 5 |
| 2023 2 | 9 | 0 | 9 |
| 2023 1 | 8 | 0 | 8 |
Show all